Results 161 to 169 of about 187,113 (169)

Thrombolytic Therapy for Acute Myocardial Infarction: GUSTO Criticized

New England Journal of Medicine, 1994
exaly  

Urgent revision of GUSTO IIa protocol

Lancet, The, 1994
exaly  

Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy

Journal of the American College of Cardiology, 2000
Christopher B Granger, Eric J Topol
exaly  

Impact of an Aggressive Invasive Catheterization and Revascularization Strategy on Mortality in Patients With Cardiogenic Shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) Trial

Circulation, 1997
Peter B Berger, Robert M Califf, Eric J Topol   +2 more
exaly  

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial

Lancet, The, 2001
exaly  

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

Lancet, The, 2001
exaly  

THROMBOLYSIS

Lancet, The, 1993
exaly  

End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators

Circulation, 1997
exaly  

El pan y la sal: hacia una poética del gusto en el epigrama de Marcial

Acta Poetica, 2010
exaly